Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of AK-120 in patients with herpes zoster
jRCT2080220058Phase 3
- Sponsor
- Asahi Kasei Pharma
- Start
- Sep 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of manfidokimab in herpes zoster (HZ), sponsored by Asahi Kasei Pharma.
02
Drugs
manfidokimab
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on jRCT2080220058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220058.